Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Kratos has strong operating momentum: second-quarter revenue increased 30.5% year over year and 19.1% organically, last-twelve-month book-to-bill reached 1.3, consolidated backlog was $2.084 billion, and the opportunity pipeline was $15.0 billion. Management raised FY2026 revenue guidance to $1.750-$1.810 billion and guided to $173-$176 million of adjusted EBITDA. The case is supported by expanding demand across hypersonics, propulsion, C5ISR, space, microwave electronics, and unmanned systems, including continuing Valkyrie mission validation and new production awards. The principal offsets are heavy capacity and working-capital investment, forecast negative free cash flow, program and funding timing, supply-chain and hiring constraints, and the execution risk inherent in rapidly scaling production.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets21 analysts · as of 18 Aug 2026
Low · most bearish analyst$60.00
Mean target$105.62
High · most bullish analyst$150.00
Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$60.0020%

Contract timing, government funding, supply-chain constraints, hiring needs, foreign-exchange pressure, or production-ramp difficulties push revenue or adjusted EBITDA below guidance; book-to-bill falls below 1.0; and investment requirements exceed the guided range without timely backlog conversion.

Base CaseCentral scenario
$105.6250%
Matches the consensus mean

Revenue and adjusted EBITDA finish within management's $1.750-$1.810 billion and $173-$176 million guidance ranges, backlog remains above $2.0 billion, and margin improvement continues while elevated investment constrains free cash flow.

Bull CaseUpside scenario
$150.0030%

Kratos reaches the upper end of FY2026 revenue and adjusted EBITDA guidance, sustains book-to-bill near or above the reported 1.3 level, converts more of its $15.0 billion opportunity pipeline, and advances Valkyrie, hypersonic, rocket-motor, and small-engine production ramps.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Second-quarter 2026 revenue grew 30.5% year over year and 19.1% organically, prompting management to raise its full-year revenue outlook.
  • Demand visibility is substantial, with $2.084 billion of consolidated backlog, $1.990 billion of last-twelve-month bookings, and a $15.0 billion bid-and-proposal pipeline.
  • Recent operating evidence includes successful USMC Valkyrie electronic-warfare and beyond-line-of-sight command-and-control testing and an approximately $35 million military-grade hardware production award.
Sign in / Sign up to read more
Key Investment Risks
  • Kratos expects elevated investment through at least 2027 and forecasts FY2026 free-cash-flow use of $85-$105 million.
  • Management identifies government funding and award timing, supply-chain disruption, parts shortages, inflation, employee sourcing, and customer-program timing as material execution variables.
  • Margin expansion depends on production scale and mix while the company absorbs bid costs, capacity expansion, acquisition integration, and adverse Israeli-shekel effects.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.